[Morphological and biological particuliarities of thymus neoplasms]

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Nature communications·2024

Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow.

Leukemia·2015

Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Leukemia·2015

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

Swiss medical weekly·2010

In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development.

Histology and histopathology·2009

Tumors that look for their springtime in APRIL.

Critical reviews in oncology/hematology·2009

[Thoracic Surgical Approaches - From Open Thoracotomy to Robot-Assisted Surgery].

Zentralblatt fur Chirurgie·2026

Postoperative Care, Perioperative Risks, and the Continuum of Care in Thoracic Surgery: A Comprehensive AI-Augmented Review of Evidence.

Zentralblatt fur Chirurgie·2026

[Value of Clinical Video Registries for Research and Teaching in Minimally Invasive and Robotic Surgery].

Zentralblatt fur Chirurgie·2026

[Rescue Resections in Thoracic Surgery for Septic Lung Carcinomas Undergoing Systemic Therapy: a Case Series].

Zentralblatt fur Chirurgie·2026

[Digital Twins in Surgery].

Zentralblatt fur Chirurgie·2026

[Preventing Complications in Hepatopancreatobiliary Surgery].

Zentralblatt fur Chirurgie·2026

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Related Experiment Videos

[Morphological and biological particuliarities of thymus neoplasms]

Related Concept Videos

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow.

Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development.

Tumors that look for their springtime in APRIL.

[Thoracic Surgical Approaches - From Open Thoracotomy to Robot-Assisted Surgery].

Postoperative Care, Perioperative Risks, and the Continuum of Care in Thoracic Surgery: A Comprehensive AI-Augmented Review of Evidence.

[Value of Clinical Video Registries for Research and Teaching in Minimally Invasive and Robotic Surgery].

[Rescue Resections in Thoracic Surgery for Septic Lung Carcinomas Undergoing Systemic Therapy: a Case Series].

[Digital Twins in Surgery].

[Preventing Complications in Hepatopancreatobiliary Surgery].

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Related Experiment Videos

[Morphological and biological particuliarities of thymus neoplasms]

Related Concept Videos

Related Articles